Literature DB >> 4004191

Comparative study of amoxicillin-clavulanic acid and cephalexin in the treatment of bacteriuria during pregnancy.

S J Pedler, A J Bint.   

Abstract

A comparative clinical trial of amoxicillin-clavulanic acid and cephalexin was carried out in 80 women with bacteriuria of pregnancy. Treatment was randomly allocated and consisted of either one tablet of amoxicillin plus clavulanic acid (250 and 125 mg, respectively) three times daily or cephalexin (250 mg) three times daily for 7 days. Overall bacteriological cure rates at 2 weeks were 77% in the amoxicillin-clavulanic acid group and 74% in the cephalexin group. At 6 weeks the respective rates were 76 and 60%. Twenty-five episodes of infection were with ampicillin-resistant strains; cure rates were 82% (2 weeks) and 80% (6 weeks) in the amoxicillin-clavulanic acid group and 85 and 64%, respectively, in the cephalexin group. Differences in cure rates were not statistically significant. No significant difference in the rate of side effects was found. In particular, no toxicity to the fetus was seen which could be ascribed to either drug. Amoxicillin-clavulanic acid would appear to be a safe and effective treatment for bacteriuria of pregnancy.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4004191      PMCID: PMC180085          DOI: 10.1128/AAC.27.4.508

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  11 in total

1.  In vitro study of clavulanic acid in combination with penicillin, amoxycillin, and carbenicillin.

Authors:  R Wise; J M Andrews; K A Bedford
Journal:  Antimicrob Agents Chemother       Date:  1978-03       Impact factor: 5.191

2.  Clavulanic acid: a beta-lactamase-inhiting beta-lactam from Streptomyces clavuligerus.

Authors:  C Reading; M Cole
Journal:  Antimicrob Agents Chemother       Date:  1977-05       Impact factor: 5.191

3.  Clavulanic acid and amoxycillin: a clinical, bacteriological, and pharmacological study.

Authors:  A P Ball; A M Geddes; P G Davey; I D Farrell; G R Brookes
Journal:  Lancet       Date:  1980-03-22       Impact factor: 79.321

4.  In vitro synergistic properties of clavulanic acid, with ampicillin, amoxycillin and ticarcillin.

Authors:  P A Hunter; K Coleman; J Fisher; D Taylor
Journal:  J Antimicrob Chemother       Date:  1980-07       Impact factor: 5.790

5.  Activities of amoxicillin and clavulanic acid combinations against urinary tract infections.

Authors:  F Crokaert; M P van der Linden; E Yourassowsky
Journal:  Antimicrob Agents Chemother       Date:  1982-08       Impact factor: 5.191

6.  Changes in sensitivity testing.

Authors:  P M Waterworth
Journal:  J Antimicrob Chemother       Date:  1983-01       Impact factor: 5.790

7.  A comparative trial of pivmecillinam and ampicillin in bacteriuria of pregnancy.

Authors:  A Bint; D Bullock; D Reeves; P Wilkinson
Journal:  Infection       Date:  1979       Impact factor: 3.553

8.  Clavulanic acid, a novel inhibitor of beta-lactamases.

Authors:  H C Neu; K P Fu
Journal:  Antimicrob Agents Chemother       Date:  1978-11       Impact factor: 5.191

9.  Prospective comparison of amoxicillin-clavulanic acid and cefaclor in treatment of uncomplicated urinary tract infections.

Authors:  M J Gurwith; G E Stein; D Gurwith
Journal:  Antimicrob Agents Chemother       Date:  1983-11       Impact factor: 5.191

10.  Amoxicillin-clavulanic acid in treatment of urinary tract infection due to gram-negative bacteria resistant to penicillin.

Authors:  R Martinelli; A A Lopes; M M de Oliveira; H Rocha
Journal:  Antimicrob Agents Chemother       Date:  1981-12       Impact factor: 5.191

View more
  9 in total

1.  Penetration of amoxicillin and potassium clavulanate into the cerebrospinal fluid of patients with inflamed meninges.

Authors:  J S Bakken; J N Bruun; P Gaustad; T C Tasker
Journal:  Antimicrob Agents Chemother       Date:  1986-09       Impact factor: 5.191

Review 2.  Beta-lactamase inhibitors from laboratory to clinic.

Authors:  K Bush
Journal:  Clin Microbiol Rev       Date:  1988-01       Impact factor: 26.132

Review 3.  Effects of antibacterials on the unborn child: what is known and how should this influence prescribing.

Authors:  A Einarson; S Shuhaiber; G Koren
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.022

Review 4.  Amoxicillin/clavulanic acid. An update of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  P A Todd; P Benfield
Journal:  Drugs       Date:  1990-02       Impact factor: 9.546

Review 5.  Different antibiotic regimens for treating asymptomatic bacteriuria in pregnancy.

Authors:  Valerie T Guinto; Blanca De Guia; Mario R Festin; Therese Dowswell
Journal:  Cochrane Database Syst Rev       Date:  2010-09-08

Review 6.  Treatments for symptomatic urinary tract infections during pregnancy.

Authors:  Juan C Vazquez; Edgardo Abalos
Journal:  Cochrane Database Syst Rev       Date:  2011-01-19

7.  First-trimester exposure to amoxycillin/clavulanic acid: a prospective, controlled study.

Authors:  Matitiahu Berkovitch; Orna Diav-Citrin; Revital Greenberg; Michal Cohen; Mordechai Bulkowstein; Svetlana Shechtman; Oxana Bortnik; Judy Arnon; Asher Ornoy
Journal:  Br J Clin Pharmacol       Date:  2004-09       Impact factor: 4.335

Review 8.  Management of bacteriuria in pregnancy.

Authors:  S J Pedler; A J Bint
Journal:  Drugs       Date:  1987-04       Impact factor: 9.546

Review 9.  Duration of treatment for asymptomatic bacteriuria during pregnancy.

Authors:  Mariana Widmer; Ivana Lopez; A Metin Gülmezoglu; Luciano Mignini; Ariel Roganti
Journal:  Cochrane Database Syst Rev       Date:  2015-11-11
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.